Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARELIFE: Individualized P2Y12 Inhibition in ACS
NCT04369534Phase 4Completed
- Sponsor
- University of Zagreb
- Start
- Dec 2015
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, ticagrelor in acute coronary syndrome (ACS), sponsored by University of Zagreb. Started Dec 2015; status: completed.
02
Drugs
clopidogrelticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04369534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04369534.